Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial.
Saved in:
| Title: | Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial. |
|---|---|
| Authors: | Meyer EH; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Salhotra A; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA., Gandhi AP; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Pantin J; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, HCA Healthcare, Nashville, TN., Patel SS; Transplant and Cellular Therapy Program, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Hoeg RT; Division of Malignant Hematology/Cellular Therapy and Transplantation, Comprehensive Cancer Center, University of California, Davis, Sacramento, CA., Gomez-Arteaga A; Weill Cornell Medicine, New York, NY., Faramand R; Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Tamari R; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Waller EK; Bone Marrow and Stem Cell Transplant Center, Winship Cancer Institute of Emory University, Atlanta, GA., Kosuri S; Division of Hematology and Oncology, University of Chicago Medicine, Chicago, IL., Jimenez Jimenez AM; Division of Transplantation and Cell Therapy, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Holter-Chakrabarty J; Transplant & Cellular Therapy Clinic, OU Health Stephenson Cancer Center, Oklahoma City, OK., Dholaria B; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Chen YB; Hematopoietic Cell Transplant and Cell Therapy Program, Massachusetts General Hospital, Boston, MA., Hamilton BK; Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH., Magenau J; Blood and Marrow Transplantation Program, Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Eghtedar A; Colorado Blood Cancer Institute, HCA HealthONE Presbyterian St. Luke's, Denver, CO., Murray JM; Orca Bio, Menlo Park, CA., Pavlova A; Orca Bio, Menlo Park, CA., Fernhoff NB; Orca Bio, Menlo Park, CA., McClellan JS; Orca Bio, Menlo Park, CA., Killian MS; Orca Bio, Menlo Park, CA., Li A; Orca Bio, Menlo Park, CA., Negrin RS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Oliai C; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA. |
| Source: | Blood [Blood] 2026 Mar 12; Vol. 147 (11), pp. 1168-1177. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
